Als Schlüsseltherapie empfohlen: Tirzepatid

CME 2026

View at publisher
Authors: Redaktion Facharztmagazine
DOI: 10.1007/s11298-026-4522-6
Cited by: 0

Fields of Study & Subjects

Diabetes Treatment and Management Pharmacology and Obesity Treatment Diabetes Management and Research

Publication details

Journal / source
CME
Volume
23
Issue
1-2
Pages
46–46
Publication date
1 February 2026
Language
DE